Citalopram
Jump to navigation
Jump to search
In psychiatry, citalopram is a second-generation antidepressant for treating major depressive disorder.
History
Efficacy
Pharmacology
Administration
Distribution
Metabolism
Citalopram is metabolised by cytochrome P-450 CYP3A4 and CYP2C19.
Excretion
Toxicity
Drug toxicity includes arrhythmias. The United States of America Food and Drug Administration has issued a warning to not use higher doses because of use of the cytochrome P-450 system and also arrhythmias.[1]
External links
The most up-to-date information about Citalopram and other drugs can be found at the following sites.
- Citalopram - FDA approved drug information (drug label) from DailyMed (U.S. National Library of Medicine).
- Citalopram - Drug information for consumers from MedlinePlus (U.S. National Library of Medicine).
- Citalopram - Detailed information from DrugBank.
References
- ↑ anonymous (2012 [last update]). Safety Alerts for Human Medical Products > Celexa (citalopram hydrobromide) - Drug Safety Communication: Revised Recommendations, Potential Risk of Abnormal Heart Rhythms. fda.gov. Retrieved on March 29, 2012.